A United Kingdom supplier, with 1 awarded contract, totalling £819k, most recently 11 months ago.
This contract involves the execution and reporting of genomic profiling tests specifically for patients diagnosed with early-stage invasive luminal HER2-negative breast cancer. The aim is to provide accurate genomic data that can assist in the treatment planning and management of these patients. The
